AstraZeneca is a leading global biopharmaceutical company that is responsible for the discovery and development of dozens of important medications that can treat and cure a range of serious illnesses. The company was officially created in 1999, when the two pharmaceutical companies Swedish Astra AB and British Zeneca Group PLC merged. Since then, it has grown in both operations and revenues to become the seventh-largest company of its kind in the world.
AstraZeneca as it exists today is a result of the 1999 merger of two major pharmaceutical companies. The first, Astra AB, was established in 1913 in Sweden. Operating internationally, Astra primarily focused its research and development resources on four main healthcare groups: gastrointestinal, respiratory, cardiovascular and pain control. The second company was called Zeneca Group PLC and was founded in 1993. In terms of the development of pharmaceuticals, they principally focussed on anaesthesia, cardiovascular, cancer, respiratory and the central nervous system.
Find out more about AstraZeneca on their website.
AstraZeneca currently employs over 57,000 people across the world, researching and developing medications for a range of illnesses and conditions. They focus particularly on cardiovascular, gastrointestinal, infection, neuroscience, oncology and respiratory pharmaceuticals. Some of AstraZeneca's successful medications currently available include Crestor, which is a statin to help lower cholesterol, and two asthma treatments, Pulmicort and Symbicort. They also manufacture the antimalarial treatments Paludrine and Avloclor, which are often prescribed in a combination treatment pack for maximum efficacy.
AstraZeneca continues to be one of the largest and most innovative pharmaceutical companies in the world. They are currently active in more than 100 countries worldwide, including in emerging markets such as Russia, Brazil and Mexico, with the highest numbers of staff operating in Europe. They continue to invest substantially in research and development in order to fulfil their goal of improving healthcare across the world, benefiting not just patients but also their own employees, shareholders and the wider community.